JARI PHARMA has obtained one new drug license， seven ANDA licenses s issued by China NMPA， formulated 7 national drug standards， applied for 11 patents， including 5 authorized invention patents. At present， nearly 20 drug applications have been completed in China with a good pass rate. In 2013 and 2016， our company was recognized as a national high-tech enterprise. JARI PHARMA is experienced in DMF registration， PAI of USA， and successful obtained the application for EU CEP Certificate. And JARI PHARMA can provide authoritative regulations and technical information requirements for drug research and development registration.